149 related articles for article (PubMed ID: 15345287)
1. Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.
Shen SW; Dolnikov A; Passioura T; Millington M; Wotherspoon S; Rice A; MacKenzie KL; Symonds G
Exp Hematol; 2004 Sep; 32(9):852-60. PubMed ID: 15345287
[TBL] [Abstract][Full Text] [Related]
2. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
3. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium.
Verhasselt B; Naessens E; De Smedt M; Plum J
Gene Ther; 2000 May; 7(10):830-6. PubMed ID: 10845720
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
[TBL] [Abstract][Full Text] [Related]
6. Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model.
Hall KM; Horvath TL; Abonour R; Cornetta K; Srour EF
Exp Hematol; 2006 Apr; 34(4):433-42. PubMed ID: 16569590
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of proliferation and differentiation of erythroid progenitors by co-transduction of erythropoietin receptor and H-ras cDNAS into single CD34(3+) cord blood cells.
Lu L; Ge Y; Li ZH; Dai MS; Broxmeyer HE
Bone Marrow Transplant; 2000 Oct; 26(8):817-22. PubMed ID: 11081379
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.
Wulf-Goldenberg A; Eckert K; Fichtner I
Eur J Cell Biol; 2008 Feb; 87(2):69-80. PubMed ID: 17931741
[TBL] [Abstract][Full Text] [Related]
9. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.
Mazurier F; Doedens M; Gan OI; Dick JE
Nat Med; 2003 Jul; 9(7):959-63. PubMed ID: 12796774
[TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.
Maher J; Colonna F; Baker D; Luzzatto L; Roberts I
Exp Hematol; 1994 Jan; 22(1):8-12. PubMed ID: 8282064
[TBL] [Abstract][Full Text] [Related]
11. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells.
Ge Y; Li ZH; Marshall MS; Broxmeyer HE; Lu L
Blood Cells Mol Dis; 1998 Jun; 24(2):124-36; discussion 137. PubMed ID: 9628849
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
Berger M; Frairia R; Piacibello W; Sanavio F; Palmero A; Venturi C; Pignochino Y; Berta L; Madon E; Aglietta M; Fagioli F
Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in human hematopoietic stem/progenitor cells.
Kuranda K; Vargaftig J; de la Rochere P; Dosquet C; Charron D; Bardin F; Tonnelle C; Bonnet D; Goodhardt M
Aging Cell; 2011 Jun; 10(3):542-6. PubMed ID: 21418508
[TBL] [Abstract][Full Text] [Related]
15. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
Zheng Y; Sun A; Han ZC
Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
[TBL] [Abstract][Full Text] [Related]
17. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
18. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
19. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
